SEC Company Response from ADC Therapeutics SA (ADCT) (CIK 0001771910) (ADCT) — Oct 3, 2019
ADC Therapeutics SA (ADCT) (CIK 0001771910)
Date: Oct. 3, 2019 · CIK: 0001771910 · Accession: 0001140361-19-017888
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233659
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Attention: Ms. Tonya K. Aldave ADC Therapeutics SA Registration Statement on Form F-1 Registration No. 333-233659
Re:
Dear Ms. Aldave,
Reference is made to our letter, filed as correspondence via EDGAR on September 30, 2019, in which we requested the acceleration of the effective date of the above-referenced registration statement for Wednesday, October 2, 2019, at 3:30 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such registration statement be declared effective at this time and we hereby formally withdraw our request for acceleration.
[Signature Page Follows]
Sincerely,
ADC Therapeutics SA
Show Raw Text
CORRESP
1
filename1.htm
October 3, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Tonya K. Aldave
Re:
ADC Therapeutics SA
Registration Statement on Form F-1
Registration No. 333-233659
Dear Ms. Aldave,
Reference is made to our letter, filed as correspondence via EDGAR on September 30, 2019, in which we requested the acceleration of the effective date of the above-referenced registration
statement for Wednesday, October 2, 2019, at 3:30 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such registration statement be declared effective at this time and we hereby
formally withdraw our request for acceleration.
[Signature Page Follows]
Sincerely,
ADC Therapeutics SA
By:
/s/ Dominique Graz
Name:
Dominique Graz
Title:
General Counsel